Investing.com – Israel stocks were higher after the close on Sunday, as gains in the Communication, Technology and Biomed sectors led shares higher. At the close in Tel Aviv, the...
Investing.com – Israel stocks were lower after the close on Monday, as losses in the Oil & Gas, Communication and Real Estate sectors led shares lower. At the close in Tel Aviv,...
Shares of Dublin-based Perrigo Co. Plc rose 1.5% in premarket trade Wednesday after the company said the U.S. Food and Drug Administration had approved a development partner's...
Perrigo Company plc (NYSE:PRGO) announced that it has completed the previously announced acquisition of privately-held Ranir Global Holdings LLC, the global leader in private...
Perrigo Company plc (NYSE:PRGO) reported first-quarter 2019 adjusted earnings of $1.07 per share, which beat the Zacks Consensus Estimate of 94 cents. However, the bottom line...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Sell||Buy||Sell|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Buy||Strong Sell|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Buy||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Bullish doji Star||1H||Current|
|Belt Hold Bearish||1W||Current|
|Dark Cloud Cover||1W||Current|
|Bullish doji Star||1M||9||Oct 18|
|Three Outside Down||5H||9||Jul 10, 2019 01:00PM|
|Falling Three Methods||1M||10||Sep 18|
Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare products and supplies infant formulas for the store brand market. It is also a provider of generic extended topical prescription products. The CHC segment is focused on the sale of OTC store brand products. The BCH segment develops, manufactures, markets and distributes various European OTC brands. The Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs. The Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.